Interferon gamma Kit ELISA
Aperçu rapide pour Interferon gamma Kit ELISA (ABIN5526764)
Antigène
Voir toutes Interferon gamma (IFNG) Kits ELISAReactivité
Méthode de détection
Type de méthode
Gamme de detection
Application
Type d'échantillon
-
-
Seuil minimal de détection
- 0.04 pg/mL
-
Fonction
- This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human IFN-γ.
-
Analytical Method
- Quantitative
-
Specificité
- IFN-γ
-
Ingrédients
- plate, standard, diluent
-
Matériel non inclus
- pipettes, tubes, reader
-
-
-
-
Volume d'échantillon
- 100 μL
-
Durée du test
- 3 - 4 h
-
Plaque
- Pre-coated
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
- Interferon gamma (IFNG)
-
Autre désignation
- IFN-gamma
-
Sujet
- Iinterferon-gamma (IFN-γ) is a dimerized soluble cytokine that is the only member of the type II class of interferons. IFN-γ, or type II interferon, is a cytokine that is critical forinnate and adaptive immunity against viral, some bacterial and protozoal infections. IFN-γ is an important activator of macrophages and inducer of Class II major histocompatibility complex (MHC) molecule expression. Aberrant IFN-γ expression is associated with a number of autoinflammatory and autoimmunediseases. The importance of IFN-γ in the immune system stems in part from its ability to inhibit viral replication directly, and most importantly from its immunostimulatory and immunomodulatory effects. IFN-γ is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 Th1 and CD8 cytotoxic T lymphocyte (CTL) effector T cells onceantigen-specific immunity develops. The role of IFN-γ as a disease marker has been demonstrated for a number of different pathological situations including infections, autoimmune diseases, transplant rejection, allergy and diabetes.
-
NCBI Accession
- NM_000619
-
UniProt
- P01579
-
Pathways
- Interferon-gamma Pathway, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy
Antigène Voir toutes Interferon gamma (IFNG) Kits ELISA
-